Action of the stable prostacyclin analogue iloprost on microvascular tone and -permeability in the hamster cheek pouch

B. Müller, M. Schmidtke, W. Witt
{"title":"Action of the stable prostacyclin analogue iloprost on microvascular tone and -permeability in the hamster cheek pouch","authors":"B. Müller,&nbsp;M. Schmidtke,&nbsp;W. Witt","doi":"10.1016/0262-1746(87)90008-4","DOIUrl":null,"url":null,"abstract":"<div><p>In order to further elucidate the mechanisms involved in therapeutic effects of prostacyclin and Iloprost in peripheral ischemic disease, the actions on microvascular tone, capillary density, and increases in venular permeability induced by inflammatory mediators and by ischemia were investigated in the cheek pouch of anaesthetized Syrian hamsters using intravital videomicroscopy and - for quantification of vascular permeability - venular leakage of fluorescein-labelled dextran (FITC-D; Mw 70,000). Iloprost at the nonhypotensive, platelet aggregation-inhibiting dose of 0.5 μg/kg/min i.v. significantly increased the diameters of arterioles and venules and the density of perfused capillaries and antagonized vasoconstriction and decrease of perfused capillary density as induced by Leukotriene D<sub>4</sub> (LTD<sub>4</sub>; 10<sup>−7</sup> M). Iloprost significantly antagonized venular leakage of FITC-D induced by histamine (10<sup>−5</sup> M), serotonin (10<sup>−5</sup> M), bradykinin (10<sup>−6</sup> M) and reperfusion after 30 min ischemia. Topical application of Iloprost (10<sup>−8</sup> M), intraarterial infusion of Prostaglandin E<sub>1</sub> (PGE<sub>1</sub>; 2.0 μg/kg/min), and topical Forskolin (10<sup>−5</sup> M) also attenuated histamine-induced venular FITC-D leakage, while topical PGE<sub>1</sub> (10<sup>−7</sup>M) and i.v. infusion of Nifedipine (30 μg/kg + 10 μg/kg/min) were not effective.</p><p>It is concluded, that microvascular effects of Iloprost by improvement of tissue perfusion and functional antagonism of mediator-induced tissue edema and vasospasm could contribute to therapeutic effectiveness in ischemic diseases.</p></div>","PeriodicalId":20720,"journal":{"name":"Prostaglandins, leukotrienes, and medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0262-1746(87)90008-4","citationCount":"54","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostaglandins, leukotrienes, and medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0262174687900084","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 54

Abstract

In order to further elucidate the mechanisms involved in therapeutic effects of prostacyclin and Iloprost in peripheral ischemic disease, the actions on microvascular tone, capillary density, and increases in venular permeability induced by inflammatory mediators and by ischemia were investigated in the cheek pouch of anaesthetized Syrian hamsters using intravital videomicroscopy and - for quantification of vascular permeability - venular leakage of fluorescein-labelled dextran (FITC-D; Mw 70,000). Iloprost at the nonhypotensive, platelet aggregation-inhibiting dose of 0.5 μg/kg/min i.v. significantly increased the diameters of arterioles and venules and the density of perfused capillaries and antagonized vasoconstriction and decrease of perfused capillary density as induced by Leukotriene D4 (LTD4; 10−7 M). Iloprost significantly antagonized venular leakage of FITC-D induced by histamine (10−5 M), serotonin (10−5 M), bradykinin (10−6 M) and reperfusion after 30 min ischemia. Topical application of Iloprost (10−8 M), intraarterial infusion of Prostaglandin E1 (PGE1; 2.0 μg/kg/min), and topical Forskolin (10−5 M) also attenuated histamine-induced venular FITC-D leakage, while topical PGE1 (10−7M) and i.v. infusion of Nifedipine (30 μg/kg + 10 μg/kg/min) were not effective.

It is concluded, that microvascular effects of Iloprost by improvement of tissue perfusion and functional antagonism of mediator-induced tissue edema and vasospasm could contribute to therapeutic effectiveness in ischemic diseases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
稳定的前列环素类似物伊洛前列素对仓鼠颊袋微血管张力和通透性的作用
为了进一步阐明前列环素和伊洛前列素治疗周围性缺血性疾病的作用机制,我们在麻醉的叙利亚仓鼠颊袋中使用活体视频显微镜研究了炎症介质和缺血诱导的微血管张力、毛细血管密度和静脉通透性增加的作用,并定量研究了荧光素标记葡聚糖(FITC-D)的静脉渗漏;70000 Mw)。非降压、血小板聚集抑制剂量0.5 μg/kg/min静脉滴注伊洛前列素可显著增加小动脉、小静脉直径和灌注毛细血管密度,拮抗白三烯D4 (LTD4)诱导的血管收缩,降低灌注毛细血管密度;Iloprost可显著抑制组胺(10−5 M)、血清素(10−5 M)、缓激肽(10−6 M)和缺血30min后再灌注引起的FITC-D静脉渗漏。局部应用伊洛前列素(10−8 M),动脉内灌注前列腺素E1 (PGE1);2.0 μg/kg/min)和外用福斯柯林(10 ~ 5 M)也能减轻组胺引起的静脉FITC-D渗漏,而外用PGE1 (10 ~ 7M)和静脉滴注硝苯地平(30 μg/kg + 10 μg/kg/min)均无效果。由此可见,伊洛前列素通过改善组织灌注、拮抗介质诱导的组织水肿和血管痉挛等微血管作用,有助于提高缺血性疾病的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Announcement Effect of OKY-046, a new thromboxane A2 synthetase inhibitor, on experimental asthma in guinea pigs Protective effect of iloprost and UK 38 485 against gastric mucosal damage induced by various stimuli Modulation of zymosan stimulated leukotriene release by dietary unsaturated fatty acids Inhibition of thromboxane B2 formation of blood platelets by trapidil and other s-triazolo(l,5-a)pyrimidine derivatives
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1